Vanguard Group Inc Exact Sciences Corp Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Vanguard Group Inc holds 17,907,459 shares of EXAS stock, worth $742 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,907,459
Previous 17,637,674
1.53%
Holding current value
$742 Million
Previous $764 Million
24.63%
% of portfolio
0.02%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding EXAS
# of Institutions
649Shares Held
157MCall Options Held
1.45MPut Options Held
2.29M-
Capital World Investors Los Angeles, CA18.2MShares$754 Million0.15% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$500 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$497 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$223 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.7MShares$153 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.33B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...